Endothelial caveolar subcellular domain regulation of endothelial nitric oxide synthase

Clinical and Experimental Pharmacology and Physiology

Volumn 40, Issue 11, 2013, Pages 753-764

  Ramadoss, Jayanth ^a   Pastore, Mayra B ^b   Magness, Ronald R ^b  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

Barker hypothesis; Caveolae; Endothelium; Nitric oxide; Vascular

Indexed keywords

ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE;

ARTICLE; CAVEOLA; CELL MEMBRANE; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; NONHUMAN; PROTEIN PROTEIN INTERACTION;

BARKER HYPOTHESIS; CAVEOLAE; ENDOTHELIUM; NITRIC OXIDE; VASCULAR;

ANIMALS; CAVEOLAE; CELL MEMBRANE; ENDOTHELIUM, VASCULAR; ENZYME ACTIVATION; HUMANS; MODELS, BIOLOGICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; PHOSPHORYLATION; PROTEIN INTERACTION DOMAINS AND MOTIFS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; SERINE; SIGNAL TRANSDUCTION; THREONINE;

EID: 84886775399     PISSN: 03051870     EISSN: 14401681     Source Type: Journal    
DOI: 10.1111/1440-1681.12136     Document Type: Article

References (93)

1. Barker DJ. The developmental origins of chronic adult disease. Acta Paediatr. Suppl. 2004; 93: 26-33.
2. Shaul PW. Regulation of endothelial nitric oxide synthase: Location, location, location. Annu. Rev. Physiol. 2002; 64: 749-74.
3. Feron O, Saldana F, Michel JB, Michel T. The endothelial nitric-oxide synthase-caveolin regulatory cycle. J. Biol. Chem. 1998; 273: 3125-8.
4. Grayson TH, Chadha PS, Bertrand PP et al. Increased caveolae density and caveolin-1 expression accompany impaired NO-mediated vasorelaxation in diet-induced obesity. Histochem. Cell Biol. 2013; 139: 309-21.
5. Williams TM, Lisanti MP. The caveolin genes: From cell biology to medicine. Ann. Med. 2004; 36: 584-95.
6. Helmreich EJM. Environmental influences on signal transduction through membranes: A retrospective mini-review. Biophys. Chem. 2003; 100: 519-34.
7. Couet J, Li S, Okamoto T, Ikezu T, Lisanti MP. Identification of peptide and protein ligands for the caveolin-scaffolding domain. Implications for the interaction of caveolin with caveolae-associated proteins. J. Biol. Chem. 1997; 272: 6525-33.
8. Traub O, Berk BC. Laminar shear stress: Mechanisms by which endothelial cells transduce an atheroprotective force. Arterioscler. Thromb. Vasc. Biol. 1998; 18: 677-85.
9. Frank PG, Woodman SE, Park DS, Lisanti MP. Caveolin, caveolae, and endothelial cell function. Arterioscler. Thromb. Vasc. Biol. 2003; 23: 1161-8.
10. Turner AJ, Hopper NM. Lipid Modification of Proteins. Oxford University Press, New York. 1992.
11. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol. Rev. 1995; 75: 519-60.
12. Boo YC, Hwang J, Sykes M et al. Shear stress stimulates phosphorylation of eNOS at Ser(635) by a protein kinase A-dependent mechanism. Am. J. Physiol. Heart Circ. Physiol. 2002; 283: H1819-28.
13. Kuiper GG, Carlsson B, Grandien K et al. Comparison of the ligand binding specificity and transcript tissue distribution of estrogen receptors alpha and beta. Endocrinology 1997; 138: 863-70.
14. Li Y, Zheng J, Bird IM, Magness RR. Effects of pulsatile shear stress on signaling mechanisms controlling nitric oxide production, endothelial nitric oxide synthase phosphorylation, and expression in ovine fetoplacental artery endothelial cells. Endothelium 2005; 12: 21-39.
15. Li Y, Zheng J, Bird IM, Magness RR. Mechanisms of shear stress-induced endothelial nitric-oxide synthase phosphorylation and expression in ovine fetoplacental artery endothelial cells. Biol. Reprod. 2004; 70: 785-96.
16. Li Y, Zheng J, Bird IM, Magness RR. Effects of pulsatile shear stress on nitric oxide production and endothelial cell nitric oxide synthase expression by ovine fetoplacental artery endothelial cells. Biol. Reprod. 2003; 69: 1053-9.
17. Mount PF, Kemp BE, Power DA. Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation. J. Mol. Cell. Cardiol. 2007; 42: 271-9.
18. Shaul PW, Smart EJ, Robinson LJ et al. Acylation targets emdothelial nitric-oxide synthase to plasmalemmal caveolae. J. Biol. Chem. 1996; 271: 6518-22.
19. Fulton D, Gratton JP, Sessa WC. Post-translational control of endothelial nitric oxide synthase: Why isn't calcium/calmodulin enough? J. Pharmacol. Exp. Ther. 2001; 299: 818-24.
20. Pastore MB, Jobe SO, Ramadoss J, Magness RR. Estrogen receptor-alpha and estrogen receptor-beta in the uterine vascular endothelium during pregnancy: Functional implications for regulating uterine blood flow. Semin Reprod. Med. 2012; 30: 46-61.
21. Mccabe TJ, Fulton D, Roman LJ, Sessa WC. Enhanced electron flux and reduced calmodulin dissociation may explain 'calcium-independent' eNOS activation by phosphorylation. J. Biol. Chem. 2000; 275: 6123-8.
22. 635 produces NO without requiring intracellular calcium increase. Free Radic. Biol. Med. 2003; 35: 729-41.
23. Cale JM, Bird IM. Dissociation of endothelial nitric oxide synthase phosphorylation and activity in uterine artery endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 2006; 290: H1433-45.
24. 2+ bursts and endothelial nitric oxide synthase activation in ovine uterine artery endothelial cells through increased connexin 43 function. Biol. Reprod. 2010; 82: 66-75.
25. Chen DB, Bird IM, Zheng J, Magness RR. Membrane estrogen receptor-dependent extracellular signal-regulated kinase pathway mediates acute activation of endothelial nitric oxide synthase by estrogen in uterine artery endothelial cells. Endocrinology 2004; 145: 113-25.
26. Goetz RM, Thatte HS, Prabhakar P, Cho MR, Michel T, Golan DE. Estradiol induces the calcium-dependent translocation of endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA 1999; 96: 2788-93.
27. Prabhakar P, Thatte HS, Goetz RM, Cho MR, Golan DE, Michel T. Receptor-regulated translocation of endothelial nitric-oxide synthase. J. Biol. Chem. 1998; 273: 27383-8.
28. Harris MB, Ju H, Venema VJ, Blackstone M, Venema RC. Role of heat shock protein 90 in bradykinin-stimulated endothelial nitric oxide release. Gen. Pharmacol. 2000; 35: 165-70.
29. Ramadoss J, Liao WX, Chen DB, Magness RR. High-throughput caveolar proteomic signature profile for maternal binge alcohol consumption. Alcohol 2010; 44: 691-7.
30. Venema RC, Sayegh HS, Kent JD, Harrison DG. Identification, characterization, and comparison of the calmodulin-binding domains of the endothelial and inducible nitric oxide synthases. J. Biol. Chem. 1996; 271: 6435-40.
31. Aoyagi M, Arvai AS, Tainer JA, Getzoff ED. Structural basis for endothelial nitric oxide synthase binding to calmodulin. EMBO J. 2003; 22: 766-75.
32. 2+-calmodulin and caveolin. J. Biol. Chem. 1997; 272: 15583-6.
33. Michel JB, Feron O, Sase K, Prabhakar P, Michel T. Caveolin versus calmodulin. Counterbalancing allosteric modulators of endothelial nitric oxide synthase. J. Biol. Chem. 1997; 272: 25907-12.
34. Hellermann GR, Solomonson LP. Calmodulin promotes dimerization of the oxygenase domain of human endothelial nitric-oxide synthase. J. Biol. Chem. 1997; 272: 12030-4.
35. Ghosh S, Gachhui R, Crooks C, Wu C, Lisanti MP, Stuehr DJ. Interaction between caveolin-1 and the reductase domain of endothelial nitric-oxide synthase. Consequences for catalysis. J. Biol. Chem. 1998; 273: 22267-71.
36. Takahashi S, Mendelsohn ME. Calmodulin-dependent and -independent activation of endothelial nitric-oxide synthase by heat shock protein 90. J. Biol. Chem. 2003; 278: 9339-44.
37. +)-calmodulin. J. Biol. Chem. 1999; 274: 33148-54.
38. Gratton JP, Fontana J, O'Connor DS, Garcia-Cardena G, McCabe TJ, Sessa WC. Reconstitution of an endothelial nitric-oxide synthase (eNOS), hsp90, and caveolin-1 complex in vitro. Evidence that hsp90 facilitates calmodulin stimulated displacement of eNOS from caveolin-1. J. Biol. Chem. 2000; 275: 22268-72.
39. Garcia-Cardena G, Fan R, Shah V et al. Dynamic activation of endothelial nitric oxide synthase by Hsp90. Nature 1998; 392: 821-4.
40. Russell KS, Haynes MP, Caulin-Glaser T, Rosneck J, Sessa WC, Bender JR. Estrogen stimulates heat shock protein 90 binding to endothelial nitric oxide synthase in human vascular endothelial cells. Effects on calcium sensitivity and NO release. J. Biol. Chem. 2000; 275: 5026-30.
41. Harris MB, Blackstone MA, Ju H, Venema VJ, Venema RC. Heat-induced increases in endothelial NO synthase expression and activity and endothelial NO release. Am. J. Physiol. Heart Circ. Physiol. 2003; 285: H333-40.
42. Takahashi S, Mendelsohn ME. Synergistic activation of endothelial nitric-oxide synthase (eNOS) by HSP90 and Akt: Calcium-independent eNOS activation involves formation of an HSP90-Akt-CaM-bound eNOS complex. J. Biol. Chem. 2003; 278: 30821-7.
43. Brouet A, Sonveaux P, Dessy C, Moniotte S, Balligand JL, Feron O. Hsp90 and caveolin are key targets for the proangiogenic nitric oxide-mediated effects of statins. Circ. Res. 2001; 89: 866-73.
44. Fontana J, Fulton D, Chen Y et al. Domain mapping studies reveal that the M domain of hsp90 serves as a molecular scaffold to regulate Akt-dependent phosphorylation of endothelial nitric oxide synthase and NO release. Circ. Res. 2002; 90: 866-73.
45. 2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells. J. Biol. Chem. 2001; 276: 32663-9.
46. Dedio J, Konig P, Wohlfart P, Schroeder C, Kummer W, Muller-Esterl W. NOSIP, a novel modulator of endothelial nitric oxide synthase activity. FASEB J. 2001; 15: 79-89.
47. Zimmermann K, Opitz N, Dedio J, Renne C, Muller-Esterl W, Oess S. Nostrin: A protein modulating nitric oxide release and subcellular distribution of endothelial nitric oxide synthase. Proc. Natl Acad. Sci. USA 2002; 99: 17167-72.
48. Su Y, Kondrikov D, Block ER. Cytoskeletal regulation of nitric oxide synthase. Cell Biochem. Biophys. 2005; 43: 439-49.
49. Dusserre N, L'Heureux N, Bell KS et al. PECAM-1 interacts with nitric oxide synthase in human endothelial cells: Implication for flow-induced nitric oxide synthase activation. Arterioscler. Thromb. Vasc. Biol. 2004; 24: 1796-802.
50. Dudzinski DM, Michel T. Life history of eNOS. Partners and pathways. Cardiovasc. Res. 2007; 75: 247-60.
51. Ramadoss J, Liao WX, Morschauser TJ et al. Endothelial caveolar hub regulation of adenosine triphosphate-induced endothelial nitric oxide synthase subcellular partitioning and domain-specific phosphorylation. Hypertension 2012; 59: 1052-9.
52. Boo YC, Jo H. Flow-dependent regulation of endothelial nitric oxide synthase: Role of protein kinases. Am. J. Physiol. Cell Physiol. 2003; 285: C499-508.
53. Sessa WC. eNOS at a glance. J. Cell Sci. 2004; 117: 2427-9.
54. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature 1999; 399: 601-5.
55. Harris MB, Ju H, Venema VJ et al. Reciprocal phosphorylation and regulation of endothelial nitric-oxide synthase in response to bradykinin stimulation. J. Biol. Chem. 2001; 276: 16.
56. +)/calmodulin-dependent endothelial nitric oxide synthase activity. Circ. Res. 2001; 88: E68-75.
57. Chen H, Montagnani M, Funahashi T, Shimomura I, Quon MJ. Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J. Biol. Chem. 2003; 278: 45021-6.
58. Thors B, Halldorsson H, Clarke GD, Thorgeirsson G. Inhibition of Akt phosphorylation by thrombin, histamine and lysophosphatidylcholine in endothelial cells. Differential role of protein kinase C. Atherosclerosis 2003; 168: 245-53.
59. 1177 via an AMPK mediated pathway independent of PI3K-Akt. FEBS Lett. 2004; 573: 175-80.
60. Dimmeler S, Dernbach E, Zeiher AM. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett. 2000; 477: 258-62.
61. Bauer PM, Fulton D, Boo YC et al. Compensatory phosphorylation and protein-protein interactions revealed by loss of function and gain of function mutants of multiple serine phosphorylation sites in endothelial nitric-oxide synthase. J. Biol. Chem. 2003; 278: 14841-9.
62. 1179 by Akt-independent mechanisms: Role of protein kinase A. J. Biol. Chem. 2002; 277: 3388-96.
63. Sanchez FA, Savalia NB, Duran RG, Lal BK, Boric MP, Duran WN. Functional significance of differential eNOS translocation. Am. J. Physiol. Heart Circ. Physiol. 2006; 291: H1058-64.
64. Salerno JC, Harris DE, Irizarry K et al. An autoinhibitory control element defines calcium-regulated isoforms of nitric oxide synthase. J. Biol. Chem. 1997; 272: 29769-77.
65. Butt E, Bernhardt M, Smolenski A et al. Endothelial nitric-oxide synthase (Type III) is activated and becomes calcium independent upon phosphorylation by cyclic nucleotide-dependent protein kinases. J. Biol. Chem. 2000; 275: 5179-87.
66. Michell BJ, Harris MB, Chen ZP et al. Identification of regulatory sites of phosphorylation of the bovine endothelial nitric-oxide synthase at serine 617 and serine 635. J. Biol. Chem. 2002; 277: 42344-51.
67. Cale JM, Bird IM. Inhibition of MEK/ERK1/2 signalling alters endothelial nitric oxide synthase activity in an agonist-dependent manner. Biochem. J. 2006; 398: 279-88.
68. Chen ZP, Mitchelhill KI, Michell BJ et al. AMP-activated protein kinase phosphorylation of endothelial NO synthase. FEBS Lett. 1999; 443: 285-9.
69. +)-calmodulin. Biochemistry 1996; 35: 14651-8.
70. Michell JB, Chen Z, Tiganis T et al. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J. Biol. Chem. 2001; 276: 17625-8.
71. Greif DM, Kou R, Michel T. Site-specific dephosphorylation of endothelial nitric oxide synthase by protein phosphatase 2A: Evidence for crosstalk between phosphorylation sites. Biochemistry 2002; 41: 15845-53.
72. Kou R, Greif D, Michel T. Dephosphorylation of endothelial nitric-oxide synthase by vascular endothelial growth factor. Implications for the vascular responses to cyclosporin A. J. Biol. Chem. 2002; 277: 29669-73.
73. Drew BG, Fidge NH, Gallon-Beaumier G, Kemp BE, Kingwell BA. High-density lipoprotein and apolipoprotein AI increase endothelial NO synthase activity by protein association and multisite phosphorylation. Proc. Natl Acad. Sci. USA 2004; 101: 6999-7004.
74. Liu J, Oh P, Horner T, Rogers RA, Schnitzer JE. Organized endothelial cell surface signal transduction in caveolae distinct from glycosylphosphatidylinositol-anchored protein microdomains. J. Biol. Chem. 1997; 272: 7211-22.
75. Lisanti MP, Scherer PE, Vidugiriene J et al. Characterization of caveolin-rich membrane domains isolated from an endothelial-rich source: Implications for human disease. J. Cell Biol. 1994; 126: 111-26.
76. Uittenbogaard A, Shaul PW, Yuhanna IS, Blair A, Smart EJ. High density lipoprotein prevents oxidized low density lipoprotein-induced inhibition of endothelial nitric-oxide synthase localization and activation in caveolae. J. Biol. Chem. 2000; 275: 11278-83.
77. Minshall RD, Tiruppathi C, Vogel SM et al. Endothelial cell-surface gp60 activates vesicle formation and trafficking via G(i)-coupled Src kinase signaling pathway. J. Cell Biol. 2000; 150: 1057-70.
78. Feng Y, Venema VJ, Venema RC, Tsai N, Behzadian MA, Caldwell RB. VEGF-induced permeability increase is mediated by caveolae. Invest. Ophthalmol. Vis. Sci. 1999; 40: 157-67.
79. Lindner V, Kim SK, Karas RH, Kuiper GG, Gustafsson JA, Mendelsohn ME. Increased expression of estrogen receptor-beta mRNA in male blood vessels after vascular injury. Circ. Res. 1998; 83: 224-9.
80. Lupu C, Goodwin CA, Westmuckett AD et al. Tissue factor pathway inhibitor in endothelial cells colocalizes with glycolipid microdomains/caveolae. Regulatory mechanism(s) of the anticoagulant properties of the endothelium. Arterioscler. Thromb. Vasc. Biol. 1997; 17: 2964-74.
81. Magness RR, Parker CR Jr, Rosenfeld CR. Systemic and uterine responses to chronic infusion of estradiol-17 beta. Am. J. Physiol. 1993; 265: E690-8.
82. Annabi B, Lachambre M, Bousquet-Gagnon N, Page M, Gingras D, Beliveau R. Localization of membrane-type 1 matrix metalloproteinase in caveolae membrane domains. Biochem. J. 2001; 353: 547-53.
83. Puyraimond A, Fridman R, Lemesle M, Arbeille B, Menashi S. MMP-2 colocalizes with caveolae on the surface of endothelial cells. Exp. Cell Res. 2001; 262: 28-36.
84. Ju H, Venema VJ, Liang H, Harris MB, Zou R, Venema RC. Bradykinin activates the Janus-activated kinase/signal transducers and activators of transcription (JAK/STAT) pathway in vascular endothelial cells: Localization of JAK/STAT signalling proteins in plasmalemmal caveolae. Biochem. J. 2000; 351: 257-64.
85. Chun M, Liyanage UK, Lisanti MP, Lodish HF. Signal transduction of a G protein-coupled receptor in caveolae: Colocalization of endothelin and its receptor with caveolin. Proc. Natl Acad. Sci. USA 1994; 91: 11728-32.
86. Patel HH, Murray F, Insel PA. Caveolae as organizers of pharmacologically relevant signal transduction molecules. Annu. Rev. Pharmacol. Toxicol. 2008; 48: 359-91.
87. Oh P, Schnitzer JE. Segregation of heterotrimeric G proteins in cell surface microdomains. G(q) binds caveolin to concentrate in caveolae, whereas G(i) and G(s) target lipid rafts by default. Mol. Biol. Cell 2001; 12: 685-98.
88. Rizzo V, Sung A, Oh P, Schnitzer JE. Rapid mechanotransduction in situ at the luminal cell surface of vascular endothelium and its caveolae. J. Biol. Chem. 1998; 273: 26323-9.
89. 2 in angiogenesis. Exp. Cell Res. 2001; 266: 31-43.
90. Losordo DW, Kearney M, Kim EA, Jekanowski J, Isner JM. Variable expression of the estrogen receptor in normal and atherosclerotic coronary arteries of premenopausal women. Circulation 1994; 89: 1501-10.
91. Yu J, Akishita M, Eto M, et al. Src kinase-mediates androgen receptor-dependent non-genomic activation of signaling cascade leading to endothelial nitric oxide synthase. Biochem. Biophys. Res. Commun. 2012; 424: 538-43.
92. Chambliss KL, Yuhanna IS, Mineo C et al. Estrogen receptor alpha and endothelial nitric oxide synthase are organized into a functional signaling module in caveolae. Circ. Res. 2000; 87: E44-52.
93. +)-dependent activation of endothelial nitric-oxide synthase. J. Biol. Chem. 1999; 274: 29529-35.